Manulife (VECO) units report 4.21% and 0.03% Veeco holdings

Rhea-AI Filing Summary

Manulife Financial Corporation and its investment subsidiaries filed an amended Schedule 13G reporting their institutional ownership of Veeco Instruments Inc. common stock as of December 31, 2025.

Manulife Investment Management (US) LLC beneficially owned 2,531,978 shares, or 4.21% of Veeco’s common stock, while Manulife Investment Management Ltd held 18,615 shares, or 0.03%. Veeco had 60,162,510 shares outstanding as of October 30, 2025. Manulife Financial Corporation itself reported no directly held shares but may be deemed to beneficially own the shares held by its subsidiaries. The filing indicates the Manulife group’s aggregate holdings are 5 percent or less of Veeco’s common stock.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Veeco Instruments Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

922417100

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 922417100

1

Names of Reporting Persons

MANULIFE FINANCIAL CORP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 922417100

1

Names of Reporting Persons

Manulife Investment Management Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 18,615.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 18,615.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

18,615.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.03 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP No. 922417100

1

Names of Reporting Persons

MANULIFE INVESTMENT MANAGEMENT (US) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,531,978.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,531,978.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,531,978.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.21 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Veeco Instruments Inc
(b)	Address of issuer's principal executive offices: 1 Terminal Drive, Plainview, NY 11803, United States
Item 2.
(a)	Name of person filing: This filing is made on behalf of Manulife Financial Corporation ("MFC") and MFC's indirect, wholly-owned subsidiaries, Manulife Investment Management (US) LLC ("MIM (US)") and Manulife Investment Management Limited ("MIML")
(b)	Address or principal business office or, if none, residence: The principal business offices of MFC and MIML are located at 200 Bloor Street East, Toronto, Ontario, Canada, M4W 1E5. The principal business office of MIM (US) is located at 197 Clarendon Street, Boston, Massachusetts 02116.
(c)	Citizenship: MFC and MIML are organized and exist under the laws of Canada. MIM (US) is organized and exists under the laws of the State of Delaware.
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 922417100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	FI
Item 4.	Ownership
(a)	Amount beneficially owned: MIM (US) has beneficial ownership of 2,531,978 shares of Common Stock and MIML has beneficial ownership of 18,615 shares of Common Stock. Through its parent-subsidiary relationship to MIM (US) and MIML, MFC may be deemed to have beneficial ownership of these same shares.
(b)	Percent of class: Of the 60,162,510 shares of Common Stock outstanding as of October 30 2025, according to the Form 10-Q filed by the issuer with the Securities and Exchange Commission on November 5, 2025, MIM (US) held 4.21% and MIML held 0.03%.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Incorporated by reference to Item 5 of the cover page pertaining to each reporting person.
	(ii) Shared power to vote or to direct the vote: Incorporated by reference to Item 6 of the cover page pertaining to each reporting person.
	(iii) Sole power to dispose or to direct the disposition of: Incorporated by reference to Item 7 of the cover page pertaining to each reporting person.
	(iv) Shared power to dispose or to direct the disposition of: Incorporated by reference to Item 8 of the cover page pertaining to each reporting person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Items 3 and 4 above.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to MIML is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

MANULIFE FINANCIAL CORP

Signature:	/s/ Graham Miller
Name/Title:	Graham Miller / Agent*
Date:	02/12/2026

Manulife Investment Management Ltd

Signature:	/s/ Christopher Walker
Name/Title:	Christopher Walker / Chief Compliance Officer
Date:	02/04/2026

MANULIFE INVESTMENT MANAGEMENT (US) LLC

Signature:	/s/ Paul M. Donahue
Name/Title:	Paul Donahue / Chief Compliance Officer
Date:	02/10/2026

Comments accompanying signature: *Signed pursuant to a Power of Attorney dated January 17, 2018 included as Exhibit A to Schedule 13F- NT filed with the Securities and Exchange Commission by Manulife Financial Corporation on January 29, 2018. The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOT Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties for whom copies are to be sent. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Exhibit Information

EXHIBIT A - JOINT FILING AGREEMENT

FAQ

What stake in Veeco Instruments (VECO) does Manulife report in this Schedule 13G/A?

Manulife’s investment subsidiaries report a combined beneficial stake of 5 percent or less in Veeco common stock. Manulife Investment Management (US) LLC holds 2,531,978 shares (4.21%), and Manulife Investment Management Ltd holds 18,615 shares (0.03%) as of the reported dates.

Which Manulife entities are reporting ownership of Veeco Instruments (VECO)?

The filing is made on behalf of Manulife Financial Corporation and its indirect, wholly owned subsidiaries Manulife Investment Management (US) LLC and Manulife Investment Management Limited. Manulife Financial may be deemed to share beneficial ownership through its parent–subsidiary relationships with these investment management entities.

How many Veeco Instruments (VECO) shares were outstanding for the ownership calculation?

The percentage ownership figures are based on 60,162,510 Veeco common shares outstanding as of October 30, 2025. That share count comes from Veeco’s Form 10-Q filed with the SEC on November 5, 2025, and underpins the 4.21% and 0.03% ownership percentages disclosed.

Does Manulife Financial Corporation itself directly hold Veeco (VECO) shares?

Manulife Financial Corporation reports directly holding zero Veeco shares, with sole and shared voting and dispositive power each listed as 0. However, through its ownership of Manulife Investment Management (US) LLC and Manulife Investment Management Limited, it may be deemed to beneficially own their reported holdings.

What does the Schedule 13G/A say about Manulife’s voting and dispositive power over Veeco (VECO) shares?

Manulife Investment Management (US) LLC reports sole voting and sole dispositive power over 2,531,978 Veeco shares, with no shared power. Manulife Investment Management Ltd reports sole voting and sole dispositive power over 18,615 shares, also with no shared voting or dispositive authority indicated in the filing.

Why is this Veeco (VECO) Schedule 13G labeled Amendment No. 3?

The document is identified as Amendment No. 3 to a previously filed Schedule 13G for Veeco common stock. This indicates Manulife and its subsidiaries are updating earlier ownership disclosures, reflecting their current beneficial holdings and confirming they now own 5 percent or less of the class.